A Randomized, Open-label, and Parallel Study to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 in Male Volunteers
Latest Information Update: 12 Apr 2022
Price :
$35 *
At a glance
- Drugs CKD-843 (Primary)
- Indications Alopecia
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 05 Apr 2022 Status changed from not yet recruiting to completed.
- 24 Mar 2021 New trial record